Paper I
2025 August (Supplementary) (2010 Scheme) · 40 marks · 120 min

Question

Prednisolone/Fluticasone in bronchial asthma.

Q140.3 marksShort Answers

Answer

Fluticasone is the appropriate choice for regular maintenance therapy — an inhaled corticosteroid delivering high local anti-inflammatory activity to the airway with minimal systemic absorption, avoiding the systemic adverse-effect burden of long-term oral steroids. Prednisolone (systemic) is reserved for severe acute exacerbations or as a short burst, not for routine long-term control, given its risk of Cushingoid features, osteoporosis, hyperglycemia, and adrenal suppression with prolonged use.

Other Years Asked


Revise MBBS
Preview